Citigroup lowered shares of UnitedHealth Group (NYSE:UNH) from a buy rating to a neutral rating in a research note issued to investors on Monday, MarketBeat Ratings reports. The firm currently has $288.00 price target on the healthcare conglomerate’s stock.

Several other analysts have also commented on the stock. Morgan Stanley increased their price target on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an overweight rating in a research report on Wednesday, September 5th. Cantor Fitzgerald reiterated a buy rating and issued a $300.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 5th. Zacks Investment Research lowered shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Thursday, May 31st. Goldman Sachs Group reiterated a buy rating and issued a $277.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Finally, Royal Bank of Canada increased their price target on shares of UnitedHealth Group from $282.00 to $284.00 and gave the company a $255.42 rating in a research report on Wednesday, July 18th. Two investment analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the stock. UnitedHealth Group has an average rating of Buy and an average target price of $272.43.

Shares of UNH opened at $262.67 on Monday. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63. UnitedHealth Group has a twelve month low of $186.00 and a twelve month high of $271.16. The stock has a market cap of $258.21 billion, a price-to-earnings ratio of 26.02, a P/E/G ratio of 1.60 and a beta of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the consensus estimate of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The company had revenue of $56.09 billion for the quarter, compared to analyst estimates of $56.10 billion. During the same period in the prior year, the business posted $2.46 earnings per share. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group will post 12.72 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 18th. Investors of record on Friday, September 7th will be paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Thursday, September 6th. UnitedHealth Group’s payout ratio is 35.75%.

UnitedHealth Group declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, June 6th that permits the company to buyback 100,000,000 outstanding shares. This buyback authorization permits the healthcare conglomerate to reacquire shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

In related news, CEO Steven H. Nelson sold 26,033 shares of the company’s stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP D Ellen Wilson sold 15,393 shares of the company’s stock in a transaction that occurred on Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the transaction, the executive vice president now directly owns 66,402 shares in the company, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. Insiders have sold 86,255 shares of company stock worth $22,571,876 in the last three months. Insiders own 0.87% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in UNH. Chicago Partners Investment Group LLC raised its stake in UnitedHealth Group by 26.5% during the second quarter. Chicago Partners Investment Group LLC now owns 920 shares of the healthcare conglomerate’s stock worth $226,000 after purchasing an additional 193 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in UnitedHealth Group by 1.2% during the second quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 17,096 shares of the healthcare conglomerate’s stock worth $4,194,000 after purchasing an additional 200 shares during the period. Ballentine Partners LLC raised its stake in UnitedHealth Group by 2.3% during the second quarter. Ballentine Partners LLC now owns 9,038 shares of the healthcare conglomerate’s stock worth $2,218,000 after purchasing an additional 202 shares during the period. Nikulski Financial Inc. raised its stake in UnitedHealth Group by 1.8% during the second quarter. Nikulski Financial Inc. now owns 11,759 shares of the healthcare conglomerate’s stock worth $2,885,000 after purchasing an additional 205 shares during the period. Finally, Trustcore Financial Services LLC raised its stake in UnitedHealth Group by 34.1% during the second quarter. Trustcore Financial Services LLC now owns 810 shares of the healthcare conglomerate’s stock worth $199,000 after purchasing an additional 206 shares during the period. 85.39% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Technical Analysis

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.